WO1999058113A3 - Novel formulation containing paroxetine - Google Patents

Novel formulation containing paroxetine Download PDF

Info

Publication number
WO1999058113A3
WO1999058113A3 PCT/GB1999/001520 GB9901520W WO9958113A3 WO 1999058113 A3 WO1999058113 A3 WO 1999058113A3 GB 9901520 W GB9901520 W GB 9901520W WO 9958113 A3 WO9958113 A3 WO 9958113A3
Authority
WO
WIPO (PCT)
Prior art keywords
formulation containing
novel formulation
containing paroxetine
paroxetine
hemihydrate
Prior art date
Application number
PCT/GB1999/001520
Other languages
French (fr)
Other versions
WO1999058113A2 (en
Inventor
David Philip Elder
Graham Stanley Leonard
Original Assignee
Smithkline Beecham Plc
David Philip Elder
Graham Stanley Leonard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to APAP/P/2000/002019A priority Critical patent/AP2000002019A0/en
Priority to IL13959499A priority patent/IL139594A0/en
Priority to AU39409/99A priority patent/AU3940999A/en
Priority to BR9910401-6A priority patent/BR9910401A/en
Application filed by Smithkline Beecham Plc, David Philip Elder, Graham Stanley Leonard filed Critical Smithkline Beecham Plc
Priority to JP2000547965A priority patent/JP2002514591A/en
Priority to CA002331871A priority patent/CA2331871A1/en
Priority to EP99922302A priority patent/EP1077682A2/en
Priority to KR1020007012706A priority patent/KR20010043574A/en
Priority to EA200001174A priority patent/EA200001174A1/en
Priority to SK1714-2000A priority patent/SK17142000A3/en
Priority to PL99344573A priority patent/PL344573A1/en
Publication of WO1999058113A2 publication Critical patent/WO1999058113A2/en
Publication of WO1999058113A3 publication Critical patent/WO1999058113A3/en
Priority to NO20005683A priority patent/NO20005683L/en
Priority to BG105010A priority patent/BG105010A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Abstract

Paroxetine hydrochloride, in a form other than the hemihydrate, which is formulated into tablets under conditions such that there is no detectable conversion to hemihydrate during the tabletting process.
PCT/GB1999/001520 1998-05-13 1999-05-13 Novel formulation containing paroxetine WO1999058113A2 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
CA002331871A CA2331871A1 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine
AU39409/99A AU3940999A (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine
BR9910401-6A BR9910401A (en) 1998-05-13 1999-05-13 New formulation containing paroxetine
KR1020007012706A KR20010043574A (en) 1998-05-13 1999-05-13 Novel Formulation Containing Paroxetine
JP2000547965A JP2002514591A (en) 1998-05-13 1999-05-13 Formulations containing new paroxetine
IL13959499A IL139594A0 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine
EP99922302A EP1077682A2 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine
APAP/P/2000/002019A AP2000002019A0 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine.
EA200001174A EA200001174A1 (en) 1998-05-13 1999-05-13 NEW READY PREPARATORY FORM CONTAINING PAROXETIN
SK1714-2000A SK17142000A3 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine
PL99344573A PL344573A1 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine
NO20005683A NO20005683L (en) 1998-05-13 2000-11-10 New formulation containing paroxetine
BG105010A BG105010A (en) 1998-05-13 2000-11-30 Medicamentous form containing paroxetine

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810181.9A GB9810181D0 (en) 1998-05-13 1998-05-13 Novel formulations
GB9810181.9 1998-05-13

Publications (2)

Publication Number Publication Date
WO1999058113A2 WO1999058113A2 (en) 1999-11-18
WO1999058113A3 true WO1999058113A3 (en) 2000-02-17

Family

ID=10831927

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1999/001520 WO1999058113A2 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine

Country Status (20)

Country Link
EP (1) EP1077682A2 (en)
JP (1) JP2002514591A (en)
KR (1) KR20010043574A (en)
CN (1) CN1308521A (en)
AP (1) AP2000002019A0 (en)
AU (1) AU3940999A (en)
BG (1) BG105010A (en)
BR (1) BR9910401A (en)
CA (1) CA2331871A1 (en)
EA (1) EA200001174A1 (en)
GB (1) GB9810181D0 (en)
HU (1) HUP0102064A2 (en)
ID (1) ID28019A (en)
IL (1) IL139594A0 (en)
NO (1) NO20005683L (en)
PL (1) PL344573A1 (en)
SK (1) SK17142000A3 (en)
TR (1) TR200003350T2 (en)
WO (1) WO1999058113A2 (en)
ZA (1) ZA200006562B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9089492B2 (en) 2000-11-20 2015-07-28 Warner Chilcott Company, Llc Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
NZ532432A (en) * 2001-10-22 2005-02-25 Synthon Bv N-formyl paroxetine compounds and their use in a synthetic route for obtaining paroxetine

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995016448A1 (en) * 1993-12-15 1995-06-22 Smithkline Beecham Plc Paroxetine tablets and process to prepare them
WO1998009963A1 (en) * 1996-09-09 1998-03-12 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
WO1998031365A1 (en) * 1997-01-15 1998-07-23 Smithkline Beecham Plc Paroxetine compositions
WO1999032092A1 (en) * 1997-12-19 1999-07-01 Smithkline Beecham Corporation Process for manufacturing bite-dispersion tablets

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995016448A1 (en) * 1993-12-15 1995-06-22 Smithkline Beecham Plc Paroxetine tablets and process to prepare them
WO1998009963A1 (en) * 1996-09-09 1998-03-12 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
WO1998031365A1 (en) * 1997-01-15 1998-07-23 Smithkline Beecham Plc Paroxetine compositions
WO1999032092A1 (en) * 1997-12-19 1999-07-01 Smithkline Beecham Corporation Process for manufacturing bite-dispersion tablets

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9089492B2 (en) 2000-11-20 2015-07-28 Warner Chilcott Company, Llc Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures

Also Published As

Publication number Publication date
BR9910401A (en) 2001-01-09
TR200003350T2 (en) 2001-03-21
IL139594A0 (en) 2002-02-10
HUP0102064A2 (en) 2002-05-29
ZA200006562B (en) 2002-02-13
WO1999058113A2 (en) 1999-11-18
NO20005683D0 (en) 2000-11-10
GB9810181D0 (en) 1998-07-08
NO20005683L (en) 2000-12-05
PL344573A1 (en) 2001-11-05
BG105010A (en) 2001-07-31
EP1077682A2 (en) 2001-02-28
SK17142000A3 (en) 2001-06-11
JP2002514591A (en) 2002-05-21
AP2000002019A0 (en) 2000-12-31
EA200001174A1 (en) 2001-06-25
CN1308521A (en) 2001-08-15
CA2331871A1 (en) 1999-11-18
ID28019A (en) 2001-05-03
AU3940999A (en) 1999-11-29
KR20010043574A (en) 2001-05-25

Similar Documents

Publication Publication Date Title
HUP0100394A3 (en) 2-phenyl substituted imidazotriazinones, process for their preparation and pharmaceutical compositions thereof
ZA200105394B (en) Diphenylurea compounds, a process for their preparation and pharmaceutical composition containing them.
CA2365412A1 (en) Orally administrable solid ribavirin dosage forms and process for making them
ZA200100864B (en) Piperidine-4-sulphonamides compounds, a process for their preparation and pharmaceutical compositions containing them.
CA2433366A1 (en) Amlodipine free base
HUP0104272A3 (en) New cyclobutendione compounds, a process for their preparation and pharmaceutical compositions containing them
WO1999058116A3 (en) Novel formulation containing paroxetine
ZA200105300B (en) 1,1- and 1,2-disubstituted cyclopropane compounds, a process for their preparation and pharmaceutical compositions containing them.
WO1999058113A3 (en) Novel formulation containing paroxetine
ZA200110517B (en) Metalloprotease inhibitors, a process for their preparation and pharmaceutical compositions containing them.
HUP0000308A2 (en) New cyano-indole serotonin-reuptake inhibitor compounds, a process for their preparation and pharmaceutical compositions containing them
CA2370956A1 (en) Method for causticisation of alkaline solutions
HK1047101A1 (en) Bicyclic amino-pyrazinone compounds, a process fortheir preparation and pharmaceutical compositions containing them.
ZA200202030B (en) Isoindoloindolone compounds, a process for their preparation and pharmaceutical compositions containing them.
AU9437698A (en) Compressed chloramine-t tablets and method for the production thereof
HK1051845A1 (en) Substituted 1 and 2 naphthol mannich bases
AU7773900A (en) Novel c13-substituted estra-1,3,5(10)-triene-3-yl-sulfamates, a method for producing the same and pharmaceutical compositions containing these compounds
MXPA03004431A (en) Novel pharmaceutical compositions having an antidiabetic action, and process for their preparation.
ZA200103065B (en) Heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane compounds, a process for their preparation and pharmaceutical compositions containing them.
AU2002223617A1 (en) Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds
IL137364A0 (en) A process for the preparation of 6,6-dimethylhept-1-en-4-yn-3-ol
AU2677201A (en) A process for the preparation of substituted benzophenones
HK1040247A1 (en) New cyclobutaindolecarboxamide compounds, a process for their preparation and pharmaceutical compositions containing them
EP1186588A4 (en) 6-hydroxy-2-naphthylcarbinol and process for the preparation thereof
ZA200101338B (en) 6-sulphamoyl-3-quinolylphosphonic acid compounds, a process for their preparation and pharmaceutical compositions containing them.

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 99808325.9

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 139594

Country of ref document: IL

ENP Entry into the national phase

Ref document number: 2331871

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 17142000

Country of ref document: SK

Ref document number: PV2000-4186

Country of ref document: CZ

Ref document number: 508089

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2000/06562

Country of ref document: ZA

Ref document number: PA/a/2000/011154

Country of ref document: MX

Ref document number: 2000/03350

Country of ref document: TR

Ref document number: 1020007012706

Country of ref document: KR

Ref document number: 200006562

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: 39409/99

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1999922302

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 200001174

Country of ref document: EA

WWP Wipo information: published in national office

Ref document number: 1999922302

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 09700269

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: PV2000-4186

Country of ref document: CZ

WWP Wipo information: published in national office

Ref document number: 1020007012706

Country of ref document: KR

WWW Wipo information: withdrawn in national office

Ref document number: 1999922302

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: PV2000-4186

Country of ref document: CZ

WWW Wipo information: withdrawn in national office

Ref document number: 1020007012706

Country of ref document: KR